Search Results for 'Dolutegravir'

Dolutegravir published presentations and documents on DocSlides.

Dolutegravir plus Rilpivirine as Maintenance Dual Therapy
Dolutegravir plus Rilpivirine as Maintenance Dual Therapy
by quinn
SWORD-1 . and SWORD-. 2. Dolutegravir plus Rilpivi...
Dolutegravir + 2 NRTIs versus Darunavir + RTV + 2 NRTIs
Dolutegravir + 2 NRTIs versus Darunavir + RTV + 2 NRTIs
by roxanne
FLAMINGO. Dolutegravir + 2 NRTIs versus Darunavir ...
Dolutegravir   vs.  Raltegravir
Dolutegravir vs. Raltegravir
by zoe
SPRING-2 Study. Dolutegravir. versus Raltegravir....
Dolutegravir ( Tivicay )
Dolutegravir ( Tivicay )
by brown
Prepared by:. Brian R. Wood, MD. David H. Spach, M...
2013 Asilomar HIV Medical Update
2013 Asilomar HIV Medical Update
by luanne-stotts
David Spach, MD. Clinical Director, Northwest AET...
New regimen for $75 a year
New regimen for $75 a year
by tawny-fly
New pricing agreement will speed up access to gen...
New  Antiretrovirals  for the Treatment
New Antiretrovirals for the Treatment
by alida-meadow
of HIV. . Convenience, tolerability, simplicity....
Dolutegravir-Lamivudine (
Dolutegravir-Lamivudine (
by audrey
Dovato. ). Last Updated: November 28, 2022. Prepar...
Update from CROI 2023: Snippets from Seattle
Update from CROI 2023: Snippets from Seattle
by scarlett
Judith S. Currier, MD, MSc. Professor of Medicine....
Antiretroviral Updates:
Antiretroviral Updates:
by tatyana-admore
New Treatments for HIV. C. Ryan Tomlin, . Pharm.D...
Superior Efficacy of Dolutegravir (DTG) Plus
Superior Efficacy of Dolutegravir (DTG) Plus
by celsa-spraggs
2 Nucleoside Reverse Transcriptase Inhibitors (NR...
MPP LICENCES AND OPPORTUNITIES FOR INTRODUCTION OF NEW PRODUCTS AND FORMULATIONS
MPP LICENCES AND OPPORTUNITIES FOR INTRODUCTION OF NEW PRODUCTS AND FORMULATIONS
by cheryl-pisano
Esteban Burrone, . July 2017. THE MEDICINES PATEN...
Projecting  the Impact of
Projecting the Impact of
by marina-yarberry
Generic. HIV . Drugs. on 90-90-90. Esteban Burr...
HIV Pharmacotherapy Focused Update
HIV Pharmacotherapy Focused Update
by yoshiko-marsland
Drew Lambert, . PharmD. lambertd@husson.edu. Huss...
HIV 2015-2016: New Agents, New Strategies
HIV 2015-2016: New Agents, New Strategies
by ellena-manuel
Learning Objectives. EARLY VS DEFERRED ART. The C...
Essentials for Optimal Care of HIV Patients
Essentials for Optimal Care of HIV Patients
by marina-yarberry
Evidence-Based Approaches. Simply Speaking. ®. ...
ACTHIV 2018:  A State-of-the-Science Conference for Frontline Health Professionals
ACTHIV 2018: A State-of-the-Science Conference for Frontline Health Professionals
by phoebe-click
ACTIVITY CODE . TD342. Antiretroviral Medications...
Dolutegravir  monotherapy
Dolutegravir monotherapy
by alexa-scheidler
Dolutegravir monotherapy vs. dolutegravir/ abac...
Heather Watts MD  Director of HIV Prevention, Program Quality Team
Heather Watts MD Director of HIV Prevention, Program Quality Team
by alida-meadow
Heather Watts MD Director of HIV Prevention, Pro...
Interactive ART Cases From the Clinic: Is There One Right Answer?
Interactive ART Cases From the Clinic: Is There One Right Answer?
by megan
Joseph J. Eron, Jr, MD. Professor of Medicine. Uni...
DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT
DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT
by jasmine
–. NAIVE ADULTS WITH HIV-1 INFECTION: 96-WEEK RE...
Dolutegravir Containing
Dolutegravir Containing
by unita
R. egimens . m. ay Need . O. ptimization for Youth...
Cases from the Clinic(ians):  Case-based Panel Discussion
Cases from the Clinic(ians): Case-based Panel Discussion
by tripp
Associate Dean for Global Health. University of Al...